Buscar

Mostrando ítems 1-10 de 41

Vaccines in leishmaniasis: advances in the last five years

Brodskyn, Claudia Ida; Oliveira, Camila Indiani de; Barral, Aldina Maria Prado; Barral Netto, Manoel (Future Drugs LTD, 2014)

Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis

Carneiro, Marcia Weber; Santos, Diego Moura; Fukutani, Kiyoshi Ferreira; Clarêncio, Jorge; Miranda, José Carlos; Brodskyn, Claudia Ida; Barral, Aldina Maria Prado; Barral Netto, Manoel; Soto, Manuel; Oliveira, Camila Indiani de (University of São Paulo, 2013)

Cutaneous leishmaniasis in northeastern Brazil: a critical appraisal of studies conducted in State of PernambucoLeishmaniose cutânea no nordeste do Brasil: uma avaliação crítica dos estudos realizados no Estado de Pernambuco

Brito, Maria Edileuza Felinto de; Andrade, Maria Sandra; Dantas-Torres, Filipe; Rodrigues, Eduardo Henrique Gomes; Cavalcanti, Milena de Paiva; Almeida, Alzira Maria Paiva de; Brandão-Filho, Sinval Pinto (2018)

Challenges and perspectives in vaccination against leishmaniasis.

Oliveira, Camila Indiani de; Nascimento, Ivan Pereira; Barral, Aldina Maria Prado; Soto, Manuel; Barral Netto, Manoel (Elsevier Ireland Ltd., 2014)

Development of a safe live Leishmania vaccine line by gene replacement.

Titus, Richard G; Gueiros Filho, Frederico J.; Freitas, Luiz Antonio Rodrigues de; Beverley, Stephen M (American Society for Microbiology, 2014)

Processo de trabalho da ESF Vida e Esperança do município de São João do Pacuí para o acompanhamento de vítimas de Leishmaniose Tegumentar Americana

Lucas Leite Cavalcante (Universidade Federal de Minas GeraisUFMG, 2015-04-11)

This paper aims to analyse existing problems in the municipality of São João do Pacuí population by the Family Health Strategy (FHS) Health and Hope. The problem identified prioritized among the various adverse situations ...

Sub-clinical infection as an effective protocol for obtaining anti-Leishmania chagasi amastigote antibodies of different animal species

Fróes, Adriana M.; Santos, Cláudia V. D. dos; Penha Filho, Manoel Leoncio da; Teixeira, Márcia Cristina Aquino; Silva, Tânia Maria Correia; Oliveira, Geraldo Gileno de Sá; dosSantos, Washington Luis Conrado; Pontes-de-Carvalho, Lain Carlos; Neves, Neuza Maria Alcântara (Elsevier, 2014)

Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.

Ramirez, Laura Garcia; Corvo, Laura; Duarte, Mariana Costa; Fumagalli, Miguel Angel Chávez; Valadares, Diogo Garcia; Santos, Diego Moura; Oliveira, Camila Indiani de; Escutia, Marta R; Alonso, Carlos; Bonay, Pedro; Tavares, Carlos Alberto Pereira; Coelho, Eduardo Antonio Ferraz; Soto, Manuel (BioMed Central, 2015)

BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge

Ramírez, Laura; Iborra, Salvador; Cortés, Jimena; Bonay, Pedro; Alonso, Carlos; Barral Netto, Manoel; Soto, Manuel (Hindawi Publishing Corporation, 2014)

Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis.

Garcia, Laura Ramírez; Santos, Diego Moura; Souza, Ana Paula Almeida de; Coelho, Eduardo Antonio Ferraz; Barral, Aldina Maria Prado; Alonso, Carlos; Escutia, Marta R; Bonay, Pedro; Oliveira, Camila Indiani de; Alvarez, Manuel Soto (Elsevier Ltd, 2014)

1
2
3
4
. . .
5